TY - JOUR
T1 - Measuring oral contraceptive adherence using self-report versus pharmacy claims data
AU - Nelson, Hallie N.
AU - Borrero, Sonya
AU - Lehman, Erik
AU - Velott, Diana L.
AU - Chuang, Cynthia H.
N1 - Funding Information:
Study data were collected and managed using REDCap electronic data capture tools hosted at the Penn State Milton S. Hershey Medical Center and College of Medicine. REDCap is supported by the Penn State Clinical & Translational Science Institute, Pennsylvania State University CTSI, NIH/NCATS Grant Number UL1 TR000127. The contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH/NCATS.
Funding Information:
This work was supported through a Patient-Centered Outcomes Research Institute (PCORI) Program Award ( CD-1304-6117 ). All statements in this report, including its findings and conclusions, are solely those of the authors and do not necessarily represent the views of PCORI, its Board of Governors or its Methodology Committee.
Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2017/12
Y1 - 2017/12
N2 - Objective Proportion of Days Covered (PDC) is a measure of medication adherence that uses prescription claims data to describe the proportion of days that the patient possessed medication. The objective of this study is to compare PDC and self-report as measures of oral contraceptive pills (OCPs) adherence and to identify individual-level predictors of adherence. Study design In a sample of 384 OCP users, self-report was compared with PDC as measures of adherence over the past 3 months. Patient-level variables were examined for associations with adherence using multivariable logistic regression models. Results High adherence, defined as missing ≤1 pill per month, was 76%, 68% and 54% as measured by self-report, PDC and both measures, respectively. Younger women (ages 18–25 and 26–33 years) were significantly less likely to have high adherence on both measures than women in the 34–40 age group [adjusted odds ratio (OR) 0.20, 95% confidence interval (CI) 0.08–0.51 and adjusted OR 0.26, 95% CI 0.11–0.62, respectively). Other predictors of high adherence on both self-report and PDC measures included being in a relationship (adjusted OR 2.30, 95% CI 1.14–4.64, compared with unpartnered women), Protestant religion (adjusted OR 2.08, 95% CI 1.07–4.06, compared with women with no religious affiliation) and higher contraceptive self-efficacy (adjusted OR 1.63, 95% CI 1.03–2.58). Conclusion PDC derived from pharmacy claims, or a combination of PDC and self-report measures, may be an alternative to self-report alone for measuring OCP adherence. Implications PDC may be a potential tool for measuring women's adherence to OCPs and should be validated in future studies.
AB - Objective Proportion of Days Covered (PDC) is a measure of medication adherence that uses prescription claims data to describe the proportion of days that the patient possessed medication. The objective of this study is to compare PDC and self-report as measures of oral contraceptive pills (OCPs) adherence and to identify individual-level predictors of adherence. Study design In a sample of 384 OCP users, self-report was compared with PDC as measures of adherence over the past 3 months. Patient-level variables were examined for associations with adherence using multivariable logistic regression models. Results High adherence, defined as missing ≤1 pill per month, was 76%, 68% and 54% as measured by self-report, PDC and both measures, respectively. Younger women (ages 18–25 and 26–33 years) were significantly less likely to have high adherence on both measures than women in the 34–40 age group [adjusted odds ratio (OR) 0.20, 95% confidence interval (CI) 0.08–0.51 and adjusted OR 0.26, 95% CI 0.11–0.62, respectively). Other predictors of high adherence on both self-report and PDC measures included being in a relationship (adjusted OR 2.30, 95% CI 1.14–4.64, compared with unpartnered women), Protestant religion (adjusted OR 2.08, 95% CI 1.07–4.06, compared with women with no religious affiliation) and higher contraceptive self-efficacy (adjusted OR 1.63, 95% CI 1.03–2.58). Conclusion PDC derived from pharmacy claims, or a combination of PDC and self-report measures, may be an alternative to self-report alone for measuring OCP adherence. Implications PDC may be a potential tool for measuring women's adherence to OCPs and should be validated in future studies.
UR - http://www.scopus.com/inward/record.url?scp=85029592151&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029592151&partnerID=8YFLogxK
U2 - 10.1016/j.contraception.2017.08.013
DO - 10.1016/j.contraception.2017.08.013
M3 - Article
C2 - 28882679
AN - SCOPUS:85029592151
SN - 0010-7824
VL - 96
SP - 453
EP - 459
JO - Contraception
JF - Contraception
IS - 6
ER -